AGAINST BRAIN CANCER: FINDING PERSONALISED THERAPIES WITH IN SILICO AND IN VITRO STRATEGIES (Q2459992): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in 2 languages: Changing unique label-description pair) |
(Changed label, description and/or aliases in 2 languages: Changing unique label-description pair) |
||
| label / it | label / it | ||
AGAINST BRAIN CANCER: FINDING PERSONALIZED THERAPIES WITH IN SILICO AND IN VITRO | AGAINST BRAIN CANCER: FINDING PERSONALIZED THERAPIES WITH IN SILICO AND IN VITRO STRATEGIES | ||
| label / en | label / en | ||
AGAINST BRAIN CANCER: FINDING PERSONALISED THERAPIES WITH IN SILICO AND IN VITRO | AGAINST BRAIN CANCER: FINDING PERSONALISED THERAPIES WITH IN SILICO AND IN VITRO STRATEGIES | ||
Revision as of 15:34, 5 November 2020
Project Q2459992 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AGAINST BRAIN CANCER: FINDING PERSONALISED THERAPIES WITH IN SILICO AND IN VITRO STRATEGIES |
Project Q2459992 in Italy |
Statements
82,091.52 Euro
0 references
164,183.03 Euro
0 references
50.0 percent
0 references
10 November 2017
0 references
30 June 2021
0 references
SISSA
0 references
45°40'37.52"N, 13°45'12.31"E
0 references
QUESTO PROGETTO PROPONE DI ESPLORARE UN APPROCCIO INNOVATIVO PER LA CURA E LA TERAPIA DEL I GLIOBLASTOMA MULTIFORME (GBM), IL PIù FREQUENTE TUMORE CEREBRALE PRIMITIVO MALIGNO, ASSOCIATO AD UNA PROGNOSI INFAUSTA. CON LE ATTUALI TERAPIE (CHIRURGIA SEGUITA DA CHEMIO E RADIO-TERAPIA) LA SOPRAVVIVENZA MEDIA Ê DI 1 ANNO. LA NATURA INFILTRANTE DEL GBM RENDE IMPOSSIBILE UN INTERVENTO CHIRURGICO RADICALE E LE CELLULE TUMORALI SVILUPPANO RAPIDAMENTE RESISTENZA ALLE TERAPIE OGGI DISPONIBILI. STUDI RECEN (Italian)
0 references
THIS PROJECT PROPOSES TO EXPLORE AN INNOVATIVE APPROACH TO THE TREATMENT AND TREATMENT OF THE GLOBLASTOMOA (GBM), THE FREQUENT EARLY BRAIN TUMOUR ASSOCIATED WITH A SHORTENED LIFE EXPECTANCY. THE AVERAGE SURVIVAL IS 1 YEAR WITH THE CURRENT TREATMENTS (CHEMO-FOLLOWED BY CHEMO AND RAPIA). THE GBM COVERT NATURE RENDERS RADICAL SURGICAL OPERATION IMPOSSIBLE AND THE CANCER CELLS RAPIDLY DEVELOP RESISTANCE TO THE THERAPIES AVAILABLE TODAY. CEN STUDIES (English)
0 references
Identifiers
G96C18000370003
0 references